These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 10833544)

  • 21. [Clinical expressions of depression].
    Scotto JC; Farisse J
    Rev Prat; 1999 Apr; 49(7):701-6. PubMed ID: 10337212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The keys to improving depression outcomes.
    Rizvi SJ; Kennedy SH
    Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S694-702. PubMed ID: 21924209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depression and heart disease: therapeutic implications.
    Somberg TC; Arora RR
    Cardiology; 2008; 111(2):75-81. PubMed ID: 18376116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical criteria in evaluating recovery from depression. Methodologic aspects].
    Ansseau M
    Encephale; 1993 Aug; 19 Spec No 3():441-4. PubMed ID: 8299542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type-D personality predicts chronic anxiety following percutaneous coronary intervention in the drug-eluting stent era.
    Spindler H; Pedersen SS; Serruys PW; Erdman RA; van Domburg RT
    J Affect Disord; 2007 Apr; 99(1-3):173-9. PubMed ID: 17049996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
    Benazzi F; Akiskal H
    J Affect Disord; 2005 Feb; 84(2-3):197-207. PubMed ID: 15708417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention.
    Pedersen SS; Denollet J; van Gestel YR; Serruys PW; van Domburg RT
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):203-9. PubMed ID: 18391649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.
    McCaffery JM; Frasure-Smith N; Dubé MP; Théroux P; Rouleau GA; Duan Q; Lespérance F
    Psychosom Med; 2006; 68(2):187-200. PubMed ID: 16554382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Depression and ischemic heart disease].
    Hanash JA; Hansen BH; Birket-Smith M
    Ugeskr Laeger; 2007 Sep; 169(38):3216; author reply 3217. PubMed ID: 17918659
    [No Abstract]   [Full Text] [Related]  

  • 31. Depression and coronary heart disease: a review for cardiologists.
    Carney RM; Freedland KE; Sheline YI; Weiss ES
    Clin Cardiol; 1997 Mar; 20(3):196-200. PubMed ID: 9068903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trait negative affect: toward an integrated model of understanding psychological risk for impairment in cardiac autonomic function.
    Bleil ME; Gianaros PJ; Jennings JR; Flory JD; Manuck SB
    Psychosom Med; 2008 Apr; 70(3):328-37. PubMed ID: 18378862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression in the medical setting: biopsychological interactions and treatment considerations.
    Evans DL; Staab JP; Petitto JM; Morrison MF; Szuba MP; Ward HE; Wingate B; Luber MP; O'Reardon JP
    J Clin Psychiatry; 1999; 60 Suppl 4():40-55; discussion 56. PubMed ID: 10086482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A national survey of cardiovascular physicians' beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease.
    Feinstein RE; Blumenfield M; Orlowski B; Frishman WH; Ovanessian S
    Cardiol Rev; 2006; 14(4):164-9. PubMed ID: 16788327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High impact of depression in heart failure: early diagnosis and treatment options.
    Norra C; Skobel EC; Arndt M; Schauerte P
    Int J Cardiol; 2008 Apr; 125(2):220-31. PubMed ID: 17662487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of depression on the prognosis of cardiovascular diseases].
    Bounhoure JP; Galinier M; Curnier D; Bousquet M; Bes A
    Bull Acad Natl Med; 2006 Nov; 190(8):1723-31; discussion 1731-2. PubMed ID: 17650755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial.
    Cowan MJ; Freedland KE; Burg MM; Saab PG; Youngblood ME; Cornell CE; Powell LH; Czajkowski SM;
    Psychother Psychosom; 2008; 77(1):27-37. PubMed ID: 18087205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction.
    Huffman JC; Smith FA; Blais MA; Beiser ME; Januzzi JL; Fricchione GL
    Am J Cardiol; 2006 Aug; 98(3):319-24. PubMed ID: 16860016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Various forms of risk factors of antidepressive agents for influencing sexual functions. Moclobemid is first choice for the therapy of sexually active patients with depression].
    Fortschr Neurol Psychiatr; 1999 May; 67(5 Suppl Unterschie):1-4. PubMed ID: 10368779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.